The adaptation of SARS-CoV-2 to humans

The process of adaptation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to humans probably had started decades ago, when its ancestor diverged from the bat coronavirus. The adaptive process comprises strategies the virus uses to overcome the respiratory tract defense barriers and replicate and shed in the host cells. These strategies include the impairment of interferon production, hiding immunogenic motifs, avoiding viral RNA detection, manipulating cell autophagy, triggering host cell death, inducing lymphocyte exhaustion and depletion, and finally, mutation and escape from immunity. In addition, SARS-CoV-2 employs strategies to take advantage of host cell resources for its benefits, such as inhibiting the ubiquitin-proteasome system, hijacking mitochondria functions, and usage of enhancing antibodies. It may be anticipated that as the tradeoffs of adaptation progress, the virus destructive burden will gradually subside. Some evidence suggests that SARS-CoV-2 will become part of the human respiratory virome, as had occurred with other coronaviruses, and coevolve with its host.

Saved in:
Bibliographic Details
Main Author: Tosta,Eduardo
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762021000100206
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0074-02762021000100206
record_format ojs
spelling oai:scielo:S0074-027620210001002062022-01-07The adaptation of SARS-CoV-2 to humansTosta,Eduardo SAR-CoV-2 adaptive evolution mutation and variants escape immunity The process of adaptation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to humans probably had started decades ago, when its ancestor diverged from the bat coronavirus. The adaptive process comprises strategies the virus uses to overcome the respiratory tract defense barriers and replicate and shed in the host cells. These strategies include the impairment of interferon production, hiding immunogenic motifs, avoiding viral RNA detection, manipulating cell autophagy, triggering host cell death, inducing lymphocyte exhaustion and depletion, and finally, mutation and escape from immunity. In addition, SARS-CoV-2 employs strategies to take advantage of host cell resources for its benefits, such as inhibiting the ubiquitin-proteasome system, hijacking mitochondria functions, and usage of enhancing antibodies. It may be anticipated that as the tradeoffs of adaptation progress, the virus destructive burden will gradually subside. Some evidence suggests that SARS-CoV-2 will become part of the human respiratory virome, as had occurred with other coronaviruses, and coevolve with its host.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.116 20212021-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762021000100206en10.1590/0074-02760210127
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Tosta,Eduardo
spellingShingle Tosta,Eduardo
The adaptation of SARS-CoV-2 to humans
author_facet Tosta,Eduardo
author_sort Tosta,Eduardo
title The adaptation of SARS-CoV-2 to humans
title_short The adaptation of SARS-CoV-2 to humans
title_full The adaptation of SARS-CoV-2 to humans
title_fullStr The adaptation of SARS-CoV-2 to humans
title_full_unstemmed The adaptation of SARS-CoV-2 to humans
title_sort adaptation of sars-cov-2 to humans
description The process of adaptation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to humans probably had started decades ago, when its ancestor diverged from the bat coronavirus. The adaptive process comprises strategies the virus uses to overcome the respiratory tract defense barriers and replicate and shed in the host cells. These strategies include the impairment of interferon production, hiding immunogenic motifs, avoiding viral RNA detection, manipulating cell autophagy, triggering host cell death, inducing lymphocyte exhaustion and depletion, and finally, mutation and escape from immunity. In addition, SARS-CoV-2 employs strategies to take advantage of host cell resources for its benefits, such as inhibiting the ubiquitin-proteasome system, hijacking mitochondria functions, and usage of enhancing antibodies. It may be anticipated that as the tradeoffs of adaptation progress, the virus destructive burden will gradually subside. Some evidence suggests that SARS-CoV-2 will become part of the human respiratory virome, as had occurred with other coronaviruses, and coevolve with its host.
publisher Instituto Oswaldo Cruz, Ministério da Saúde
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762021000100206
work_keys_str_mv AT tostaeduardo theadaptationofsarscov2tohumans
AT tostaeduardo adaptationofsarscov2tohumans
_version_ 1756383923071352833